{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:40:19Z","timestamp":1790876419856,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ejogrb.2015.09.008","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T22:05:50Z","timestamp":1442095550000},"page":"141-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages"],"prefix":"10.1016","volume":"194","author":[{"given":"Beata","family":"Kotowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Fuksiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Sobiczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Spiewankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jonska-Gmyrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Skrzypczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kowalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2015.09.008_bib0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2009.12.033","article-title":"Quality of care in advanced ovarian cancer: the importance of provider specialty","volume":"117","author":"Mercado","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3802\/jgo.2014.25.2.111","article-title":"Comparison of laparoscopy and laparotomy for the management of early-stage ovarian cancer: surgical and oncological outcomes","volume":"25","author":"Koo","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2010.09.002","article-title":"Status of tumor markers in epithelial ovarian cancer has there been any progress? A review","volume":"120","author":"Husseinzadeh","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s13277-011-0204-3","article-title":"HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases","volume":"32","author":"Molina","year":"2011","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0135","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/IGC.0000000000000218","article-title":"The role of HE4 in ovarian cancer follow-up: a review","volume":"24","author":"Piovano","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0140","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/IGC.0000000000000181","article-title":"Prognostic value of serum HE4 levels and Risk of Ovarian Malignancy Algorithm scores at the time of ovarian cancer diagnosis","volume":"24","author":"Kaijser","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0145","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/IGC.0b013e318249bee7","article-title":"Serum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic disease","volume":"22","author":"Zheng","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2214\/AJR.09.3936","article-title":"Current update on borderline ovarian neoplasms","volume":"194","author":"Lalwani","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0155","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs","author":"Tavassoli","year":"2003"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0160","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1007\/s13277-014-1945-6","article-title":"HE4, CA125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer","volume":"35","author":"Ortiz-Mu\u00f1oz","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1757-2215-6-45","article-title":"The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors","volume":"6","author":"Lawicki","year":"2013","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00404-013-2722-2","article-title":"Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?","volume":"288","author":"Azzam","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0175","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","article-title":"No benefit from combining HE4 and CA 125 as ovarian tumor markers in a clinical setting","volume":"121","author":"Jacob","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0180","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1177\/147323001103900507","article-title":"The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis","volume":"39","author":"Gao","year":"2011","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1757-2215-7-49","article-title":"Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) \u2013 a study of the TOC Consortium","volume":"7","author":"Braicu","year":"2014","journal-title":"J Ovarian Res"},{"issue":"1","key":"10.1016\/j.ejogrb.2015.09.008_bib0190","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12032-013-0808-0","article-title":"HE4 combined with CA125: favorable screening tool for ovarian cancer","volume":"31","author":"Ghasemi","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0195","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","article-title":"Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and non malignant diseases","volume":"57","author":"Escudero","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0200","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1007\/s13277-014-1811-6","article-title":"Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis","volume":"35","author":"Wang","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7314\/APJCP.2014.15.1.101","article-title":"HE4 as a serum biomarker for ROMA prediction and prognosis of epithelial ovarian cancer","volume":"15","author":"Chen","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0210","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s13277-014-2738-7","article-title":"Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women","volume":"36","author":"Fujiwara","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0215","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1158\/1055-9965.EPI-13-1361","article-title":"Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women","volume":"23","author":"Karlan","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejogrb.2015.09.008_bib0220","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejogrb.2011.05.021","article-title":"Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer","volume":"158","author":"Paek","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211515003139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211515003139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:43:26Z","timestamp":1784904206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211515003139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":22,"alternative-id":["S0301211515003139"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2015.09.008","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2015.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}